Accès ouvert

Clinical Value of Procalcitonin as a Biomarker for Detecting a Primary Tuberculous Spinal Infection: Case Report and Review of the Literature.

Article scientifique 2024 Anglais

Résumé

Procalcitonin is a biomarker, potentially useful in the diagnosis of sepsis and severe bacterial infections. Few studies have examined the usefulness of this biological marker in the diagnosis of tuberculous spondylodiscitis. We report the case of a 37-year-old woman with an unremarkable medical history who was newly diagnosed with tuberculous spondylodiscitis while the procalcitonin test was negative. This case confirms the hypothesis that procalcitonin is not a useful parameter to support the diagnosis of primary tuberculous spondylodiscitis.

Citer ce document

Lahlou, Y., Dokponou, Y., Malihy, Z., Benaissa, E., Maleb, A., Elouennass, M., Chadli, M. (2024). Clinical Value of Procalcitonin as a Biomarker for Detecting a Primary Tuberculous Spinal Infection: Case Report and Review of the Literature.. https://doi.org/10.1099/acmi.0.000788.v1

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Statistiques

Consultations : 1

Téléchargements : 0